Cancer cells can promote tumor cell‐induced platelet aggregation by expressing several platelet receptors such as GPIb and GPIIbIIIa, which promote interactions with platelet bridging proteins von-Willebrand’s factor, fibronectin and fibrinogen. Here, FN1 is linked to neoplasm.